Cargando…

Multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: interrupted time series evaluation of effectiveness

BACKGROUND: Active consideration of effective medications to treat alcohol use disorder (AUD) is a consensus standard of care, yet knowledge and use of these medications are very low across diverse settings. This study evaluated the overall effectiveness a multifaceted academic detailing program to...

Descripción completa

Detalles Bibliográficos
Autores principales: Harris, Alex H. S., Bowe, Thomas, Hagedorn, Hildi, Nevedal, Andrea, Finlay, Andrea K., Gidwani, Risha, Rosen, Craig, Kay, Chad, Christopher, Melissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025587/
https://www.ncbi.nlm.nih.gov/pubmed/27633982
http://dx.doi.org/10.1186/s13722-016-0063-8
_version_ 1782453982554226688
author Harris, Alex H. S.
Bowe, Thomas
Hagedorn, Hildi
Nevedal, Andrea
Finlay, Andrea K.
Gidwani, Risha
Rosen, Craig
Kay, Chad
Christopher, Melissa
author_facet Harris, Alex H. S.
Bowe, Thomas
Hagedorn, Hildi
Nevedal, Andrea
Finlay, Andrea K.
Gidwani, Risha
Rosen, Craig
Kay, Chad
Christopher, Melissa
author_sort Harris, Alex H. S.
collection PubMed
description BACKGROUND: Active consideration of effective medications to treat alcohol use disorder (AUD) is a consensus standard of care, yet knowledge and use of these medications are very low across diverse settings. This study evaluated the overall effectiveness a multifaceted academic detailing program to address this persistent quality problem in the US Veterans Health Administration (VHA), as well as the context and process factors that explained variation in effectiveness across sites. METHODS: An interrupted time series design, analyzed with mixed-effects segmented logistic regression, was used to evaluate changes in level and rate of change in the monthly percent of patients with a clinically documented AUD who received naltrexone, acamprosate, disulfiram, or topiramate. Using data from a 20 month post-implementation period, intervention sites (n = 37) were compared to their own 16 month pre-implementation performance and separately to the rest of VHA. RESULTS: From immediately pre-intervention to the end of the observation period, the percent of patients in the intervention sites with AUD who received medication increased over 3.4 % in absolute terms and 68 % in relative terms (i.e., 4.9–8.3 %). This change was significant compared to the pre-implementation period in the intervention sites and secular trends in control sites. Sites with lower pre-implementation adoption, more person hours of detailing, but fewer people detailed, had larger immediate increases in medication receipt after implementation. The average number of detailing encounters per person was associated with steeper increases in slope over time. CONCLUSIONS: This study found empirical support for a multifaceted quality improvement strategy aimed at increasing access to and utilization of pharmacotherapy for AUD. Future studies should focus on determining how to enhance the programs effects, especially in non-responsive locations.
format Online
Article
Text
id pubmed-5025587
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50255872016-09-20 Multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: interrupted time series evaluation of effectiveness Harris, Alex H. S. Bowe, Thomas Hagedorn, Hildi Nevedal, Andrea Finlay, Andrea K. Gidwani, Risha Rosen, Craig Kay, Chad Christopher, Melissa Addict Sci Clin Pract Research BACKGROUND: Active consideration of effective medications to treat alcohol use disorder (AUD) is a consensus standard of care, yet knowledge and use of these medications are very low across diverse settings. This study evaluated the overall effectiveness a multifaceted academic detailing program to address this persistent quality problem in the US Veterans Health Administration (VHA), as well as the context and process factors that explained variation in effectiveness across sites. METHODS: An interrupted time series design, analyzed with mixed-effects segmented logistic regression, was used to evaluate changes in level and rate of change in the monthly percent of patients with a clinically documented AUD who received naltrexone, acamprosate, disulfiram, or topiramate. Using data from a 20 month post-implementation period, intervention sites (n = 37) were compared to their own 16 month pre-implementation performance and separately to the rest of VHA. RESULTS: From immediately pre-intervention to the end of the observation period, the percent of patients in the intervention sites with AUD who received medication increased over 3.4 % in absolute terms and 68 % in relative terms (i.e., 4.9–8.3 %). This change was significant compared to the pre-implementation period in the intervention sites and secular trends in control sites. Sites with lower pre-implementation adoption, more person hours of detailing, but fewer people detailed, had larger immediate increases in medication receipt after implementation. The average number of detailing encounters per person was associated with steeper increases in slope over time. CONCLUSIONS: This study found empirical support for a multifaceted quality improvement strategy aimed at increasing access to and utilization of pharmacotherapy for AUD. Future studies should focus on determining how to enhance the programs effects, especially in non-responsive locations. BioMed Central 2016-09-15 2016 /pmc/articles/PMC5025587/ /pubmed/27633982 http://dx.doi.org/10.1186/s13722-016-0063-8 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Harris, Alex H. S.
Bowe, Thomas
Hagedorn, Hildi
Nevedal, Andrea
Finlay, Andrea K.
Gidwani, Risha
Rosen, Craig
Kay, Chad
Christopher, Melissa
Multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: interrupted time series evaluation of effectiveness
title Multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: interrupted time series evaluation of effectiveness
title_full Multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: interrupted time series evaluation of effectiveness
title_fullStr Multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: interrupted time series evaluation of effectiveness
title_full_unstemmed Multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: interrupted time series evaluation of effectiveness
title_short Multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: interrupted time series evaluation of effectiveness
title_sort multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: interrupted time series evaluation of effectiveness
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025587/
https://www.ncbi.nlm.nih.gov/pubmed/27633982
http://dx.doi.org/10.1186/s13722-016-0063-8
work_keys_str_mv AT harrisalexhs multifacetedacademicdetailingprogramtoincreasepharmacotherapyforalcoholusedisorderinterruptedtimeseriesevaluationofeffectiveness
AT bowethomas multifacetedacademicdetailingprogramtoincreasepharmacotherapyforalcoholusedisorderinterruptedtimeseriesevaluationofeffectiveness
AT hagedornhildi multifacetedacademicdetailingprogramtoincreasepharmacotherapyforalcoholusedisorderinterruptedtimeseriesevaluationofeffectiveness
AT nevedalandrea multifacetedacademicdetailingprogramtoincreasepharmacotherapyforalcoholusedisorderinterruptedtimeseriesevaluationofeffectiveness
AT finlayandreak multifacetedacademicdetailingprogramtoincreasepharmacotherapyforalcoholusedisorderinterruptedtimeseriesevaluationofeffectiveness
AT gidwanirisha multifacetedacademicdetailingprogramtoincreasepharmacotherapyforalcoholusedisorderinterruptedtimeseriesevaluationofeffectiveness
AT rosencraig multifacetedacademicdetailingprogramtoincreasepharmacotherapyforalcoholusedisorderinterruptedtimeseriesevaluationofeffectiveness
AT kaychad multifacetedacademicdetailingprogramtoincreasepharmacotherapyforalcoholusedisorderinterruptedtimeseriesevaluationofeffectiveness
AT christophermelissa multifacetedacademicdetailingprogramtoincreasepharmacotherapyforalcoholusedisorderinterruptedtimeseriesevaluationofeffectiveness